Pharmadrug (PHRX) Stock Statistics & Valuation Metrics

Pharmadrug has a market cap or net worth of C$1.08M. The enterprise value is C$4.80M.

Pharmadrug has 108,234,380 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmadrug’s return on equity (ROE) is 7.74 and return on invested capital (ROIC) is -412.08%.

The current PE Ratio of Pharmadrug is -0.21. Pharmadrug’s PEG ratio is >-0.01.

In the last 12 months, Pharmadrug had revenue of 0.00 and earned -13.20M in profits. Earnings per share was -0.23.

In the last 12 months, operating cash flow was -1.13M and capital expenditures 0.00, giving a free cash flow of -1.13M billion.

Pharmadrug pays an annual dividend of ―, resulting in a dividend yield of ―

Pharmadrug upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.

Pharmadrug as a current ratio of 0.22, with Debt / Equity ratio of -103.65%

In the past 12 months, Pharmadrug has paid -1.01M in taxes.

Pharmadrug EV to EBITDA ratio is -3.13, with an EV/FCF ratio of -6.22.

Pharmadrug has C$128.12K in cash and marketable securities with C$1.40M in debt, giving a net cash position of C$1.27M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Pharmadrug is ―, which is 11.43% higher than the current price. The consensus rating is ―